GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3359)

  • GC79675 structure
    GC79675FTO-IN-17
    CAS: 1434867-98-7
    Purity: >98.00%

    FTO-IN-17 is an orally active and brain-penetrant FTO (m 6 A RNA demethylase) inhibitor with an IC 50 of 1.1 μM.

  • GC79709 structure
    GC79709HK2-IN-4
    CAS: 2748366-80-3
    Purity: >99.50%

    HK2-IN-4 is a selective hexokinase 2 ( HK2 ) inhibitor with an IC 50 value of 0.79 μM and a K d value of 0.41 μM.

  • GC79725 structure
    GC79725DI-1548
    CAS: 2247060-97-3
    Purity: >98.00%

    DI-1548 is a potent, selective, and irreversible covalent inhibitor of DCN1 ( IC 50 = 4.6 nM).

  • GC79757 structure
    GC79757ALOX5 stabilizer-1 TFA
    Purity: >98.00%

    ALOX5 stabilizer-1 TFA is an arachidonate 5-lipoxygenase ( ALOX5 ) stabilizer with a K d of 7.26 μM.

  • GC79758 structure
    GC79758PAI-1-IN-1
    CAS: 1247823-40-0
    Purity: >99.00%

    PAI-1-IN-1 is an orally active and specific PAI-1 inhibitor with an IC 50 of <6.95 μM.

  • GC79806 structure
    GC79806TKL002
    CAS: 3098518-95-4
    Purity: >98.00%

    TKL002 is a blood-brain barrier-permeable inhibitor of the CTH/H 2 S/NF-κB/EMT signaling axis.

  • GC79807 structure
    GC79807RP-182 acetate
    Purity: >98.50%

    RP-182 acetate is a synthetic immunomodulatory peptide that exerts anti-tumor effects by targeting the mannose receptor CD206 ( K d = 8 μM) on the surface of tumor-associated macrophages (TAMs).

  • GC79814 structure
    GC79814Isosorbide di-(methyl fumarate)
    CAS: 2013542-44-2
    Purity: >99.50%

    Isosorbide di-(methyl fumarate) (IDMF), topical DMF derivative, is an NRF2/ARE pathway activator.

  • GC79815 structure
    GC79815(E/Z)-Sinigrin free base
    CAS: 534-69-0
    Purity: >98.00%

    (E/Z)-Sinigrin ((E/Z)-Allyl-glucosinolate; (E/Z)-2-Propenyl-glucosinolate) free base is an orally active aliphatic thioglucoside anti-leukemia compound.

  • GC79816 structure
    GC79816Cryptolepine
    CAS: 480-26-2
    Purity: >98.00%

    Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties.

  • GC79842 structure
    GC79842Citric acid-d 4 trisodium
    CAS: 2704-20-3
    Purity: >98.00%

    Citric acid-d 4 trisodium (Sodium citrate-d 4 ) is the deuterium labeled Citric acid trisodium.

  • GC79862 structure
    GC79862Sulfaphenazole-d 4
    CAS: 2702538-04-1
    Purity: >99.50%

    Sulfaphenazole -d 4 is the deuterium labeled Sulfaphenazole.

  • GC79865 structure
    GC79865Sildenafil-d 3 citrate
    Purity: >98.00%

    Sildenafil-d 3 citrate (UK-92480-d 3 citrate) is the deuterium labeled Sildenafil citrate.

  • GC79866 structure
    GC79866Gem-C12
    CAS: 849139-19-1
    Purity: >99.00%

    Gem-C12 is a prodrug of Gemcitabine.

  • GC79867 structure
    GC79867Prexasertib-d 4
    Purity: >98.00%

    Prexasertib -d 4 (LY2606368-d 4 ) is the deuterium labeled Prexasertib.

  • GC79868 structure
    GC79868HJ-4
    CAS: 1313741-00-2
    Purity: >98.00%

    HJ-4 is a Piperine derivative.

  • GC79869 structure
    GC798692-Tetralone
    CAS: 530-93-8
    Purity: >99.50%

    2-Tetralone (Beta-Tetralone) is a cyclic bis-sterically hindered ketone and a ketone derivative of tetrafluoramine.

  • GC79870 structure
    GC79870Sar10
    CAS: 2375600-72-7
    Purity: >98.00%

    Sar10 (Compound 1) is a component of a bicyclic peptide sequence (βAla-Sar10-A-) for synthesis of multimeric CD137 -binding/activating bicyclic peptide ligands [1] .

  • GC79871 structure
    GC79871CHNQD-00824
    CAS: 2222643-74-3
    Purity: >98.00%

    CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect.

  • GC79874 structure
    GC79874Olsalazine-d 6
    Purity: >95.50%

    Olsalazine -d 6 is the deuterium labeled Olsalazine.

  • GC79875 structure
    GC79875TL02-59-d 5
    Purity: >98.00%

    TL02-59 -d 5 is the deuterium labeled TL02-59.

  • GC79876 structure
    GC79876Rimiducid-d 4
    Purity: >99.00%

    Rimiducid -d 4 (AP1903-d 4 ) is the deuterium labeled Rimiducid.

  • GC79877 structure
    GC79877Hexestrol-d 4
    CAS: 91889-42-8
    Purity: >97.00%

    Hexestrol -d 4 is the deuterium labeled Hexestrol.

  • GC79976 structure
    GC79976Chitosan oligosaccharide (MW 2000)
    Purity: >98.00%

    Chitosan oligosaccharide (MW 2000) is a natural oligomer derived from chitosan, with a molecular weight of 2000 Da.